Free Trial

State of New Jersey Common Pension Fund D Sells 6,060 Shares of Xylem Inc. $XYL

Xylem logo with Business Services background

Key Points

  • The State of New Jersey Common Pension Fund D reduced its stake in Xylem Inc. by 7.0%, selling 6,060 shares and now holding 80,169 shares valued at approximately $9.58 million.
  • Xylem reported $1.26 earnings per share, exceeding analysts' expectations of $1.15 and showing a 6.1% year-over-year revenue growth.
  • The company announced a quarterly dividend of $0.40 per share with a dividend yield of 1.1%, payable to stockholders on September 25th.
  • Need better tools to track Xylem? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

State of New Jersey Common Pension Fund D reduced its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 7.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 80,169 shares of the industrial products company's stock after selling 6,060 shares during the period. State of New Jersey Common Pension Fund D's holdings in Xylem were worth $9,577,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Dynamic Advisor Solutions LLC acquired a new position in Xylem in the 1st quarter valued at approximately $694,000. Farther Finance Advisors LLC grew its stake in shares of Xylem by 30.4% in the first quarter. Farther Finance Advisors LLC now owns 1,797 shares of the industrial products company's stock worth $215,000 after purchasing an additional 419 shares during the last quarter. NBC Securities Inc. acquired a new stake in Xylem in the first quarter valued at $72,000. GAMMA Investing LLC raised its position in Xylem by 29.1% during the 1st quarter. GAMMA Investing LLC now owns 4,241 shares of the industrial products company's stock worth $507,000 after purchasing an additional 956 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its holdings in Xylem by 19.4% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 27,215 shares of the industrial products company's stock worth $3,251,000 after buying an additional 4,429 shares during the period. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Trading Down 0.8%

NYSE:XYL opened at $140.77 on Monday. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $145.33. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $34.26 billion, a price-to-earnings ratio of 36.56, a PEG ratio of 2.44 and a beta of 1.11. The firm has a fifty day simple moving average of $132.82 and a two-hundred day simple moving average of $125.89.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The company had revenue of $2.30 billion for the quarter, compared to analysts' expectations of $2.20 billion. During the same quarter in the prior year, the firm earned $1.09 EPS. The business's revenue was up 6.1% on a year-over-year basis. Analysts expect that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be issued a dividend of $0.40 per share. The ex-dividend date is Thursday, August 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. Xylem's payout ratio is currently 41.56%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on XYL. JPMorgan Chase & Co. assumed coverage on Xylem in a research note on Friday, May 30th. They issued an "overweight" rating and a $148.00 price target for the company. Citigroup restated a "buy" rating and set a $152.00 price target (up previously from $137.00) on shares of Xylem in a report on Monday, July 14th. Robert W. Baird dropped their price target on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 30th. Royal Bank Of Canada increased their price objective on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Finally, Stifel Nicolaus lifted their target price on shares of Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $151.57.

View Our Latest Analysis on Xylem

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Read More

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten
Palantir’s Soaring Valuation—Justified or Overhyped?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines